Basic Information
| LncRNA/CircRNA Name | lncRNA-ATB |
| Synonyms | LOC109207222 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR |
| Sample | cervical cacner tissues, cell lines (SiHa, HeLa, CaSki, MS750, and C33A) |
| Expression Pattern | up-regulated |
| Function Description | LncRNA ATB was upregulated in cervical cancer cell lines and tissues (P < 0.05). Survival analysis indicated that patients with high ATB expression had a significantly shorter OS (P < 0.001) or PFS (P < 0.001) than those with low ATB expression |
| Pubmed ID | 29237907 |
| Year | 2017 |
| Title | Long noncoding RNA activated by transforming growth factor-B promotes cancer development and is a prognostic marker in cervical cancer |
External Links
| Links for lncRNA-ATB | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |